Testicular Leydig Cell Hyperplasia as a Cause of Familial Sexual Precocity*
The DOI matches its Crossref record.
Abstract
Testicular Leydig cell hyperplasia was observed in two brothers presenting with progressive sexual precocity at 2 yr of age. Virilization was shown to result from increased secretion rather than decreased clearance of gonadal testosterone. Testosterone hypersecretion appeared to be gonadotropin independent, as basal and gonadotropin-releasing hormone-induced serum LH concentrations were low by both RIA and bioassay. Adrenal steroidogenesis was demonstrated to be normal by ACTH stimulation, dexamethasone suppression, and split adrenal venous function tests. Testicular histology revealed immature reproductive structures in the 2 yr old, but advanced spermatogenesis in the 3 yr-old brother. The etiology of both Leydig cell hyperplasia and reproductive testicular maturation in the absence of significant gonadotropin secretion remains to be established.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cited by
Themmen, A. P. N., & Huhtaniemi, I. T. (2000) · Endocrine Reviews · doi:10.1210/edrv.21.5.0409 · Cited by 774
Shenker, A., Laue, L., Kosugi, S., Merendino, J. J., Minegishi, T., & Cutler, G. B. (1993) · Nature · doi:10.1038/365652a0 · Cited by 745
PPARα Agonist-Induced Rodent Tumors: Modes of Action and Human Relevance
Klaunig, J. E., Babich, M. A., Baetcke, K. P., Cook, J. C., Corton, J. C., David, R. M., DeLuca, J. G., Lai, D. Y., McKee, R. H., Peters, J. M., et al. (2003) · Critical Reviews in Toxicology · doi:10.1080/713608372 · Cited by 611
10.1016/b978-1-4160-2911-3.50026-1
(2000) · CrossRef Listing of Deleted DOIs · doi:10.1016/b978-1-4160-2911-3.50026-1 · Cited by 554
Lipedema: An inherited condition
Child, A. H., Gordon, K. D., Sharpe, P., Brice, G., Ostergaard, P., Jeffery, S., & Mortimer, P. S. (2010) · American Journal of Medical Genetics Part A · doi:10.1002/ajmg.a.33313 · Cited by 329
Familial central precocious puberty suggests autosomal dominant inheritance
de Vries, L., Kauschansky, A., Shohat, M., & Phillip, M. (2004) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2003-030361 · Cited by 195
“However, most of the documented cases were males (13), with support provided later by clinical and molecular studies of familial testotoxicosis (14).”
BackgroundTreatment of familial male-limited precocious puberty with bicalutamide and anastrozole
Kreher, N. C., Pescovitz, O. H., Delameter, P., Tiulpakov, A., & Hochberg, Z. (2006) · The Journal of Pediatrics · doi:10.1016/j.jpeds.2006.04.027 · Cited by 59
Treatment of familial male precocious puberty with spironolactone, testolactone, and deslorelin
Laue, L. (1993) · Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.76.1.151 · Cited by 56
Bicalutamide and Third-Generation Aromatase Inhibitors in Testotoxicosis
Lenz, A. M., Shulman, D., Eugster, E. A., Rahhal, S., Fuqua, J. S., Pescovitz, O. H., & Lewis, K. A. (2010) · Pediatrics · doi:10.1542/peds.2010-0596 · Cited by 55
Juel Mortensen, L., Blomberg Jensen, M., Christiansen, P., Rønholt, A.-M., Jørgensen, A., Frederiksen, H., Nielsen, J. E., Loya, A. C., Grønkær Toft, B., Skakkebæk, N. E., et al. (2017) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2017-01761 · Cited by 12
Spontaneous fertility in a male patient with testotoxicosis despite suppression of FSH levels
Cunha-Silva, M., Brito, V. N., Macedo, D. B., Bessa, D. S., Ramos, C. O., Lima, L. G., Barroso, P. S., Arnhold, I. J. P., Segaloff, D. L., Mendonca, B. B., et al. (2018) · Human Reproduction · doi:10.1093/humrep/dey049 · Cited by 6
Metadata
- Authors
- SCHEDEWIE, H. K., REITER, E. O., BEITINS, I. Z., SEYED, S., WOOTEN, V. D., JIMENEZ, J. F., AIMAN, E. J., DEVANE, G. W., REDMAN, J. F., & ELDERS, M. J.
- Venue
- The Journal of Clinical Endocrinology & Metabolism
- Publisher
- The Endocrine Society
- Published
- 1981-02
- Volume
- 52
- Issue
- 2
- Pages
- 271-278
- ISSN
- 0021-972X (ISSN-L)
- 1945-7197
- OpenAlex
- W2143305456
- Cited by
- 126
- References
- 0
- FWCI
- 0.85
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.